Rom&aacute;n-Mel&eacute;ndez GD, Monaco DR, Montagne JM, Quizon RS, Konig MF, Astatke M, Darrah E, Larman HB.

*EBioMedicine* &middot; September 2021 &middot; DOI: [10.1016/j.ebiom.2021.103506](https://doi.org/10.1016/j.ebiom.2021.103506)

 How to cite

### AMA

Rom&aacute;n-Mel&eacute;ndez GD, Monaco DR, Montagne JM, et al. Citrullination of a phage-displayed human peptidome library reveals the fine specificities of rheumatoid arthritis-associated autoantibodies. *EBioMedicine*. 2021;71:103506. doi:10.1016/j.ebiom.2021.103506

### APA

```
Rom&aacute;n-Mel&eacute;ndez, G. D., Monaco, D. R., Montagne, J. M., Quizon, R. S., Konig, M. F., Astatke, M., Darrah, E., & Larman, H. B. (2021). Citrullination of a phage-displayed human peptidome library reveals the fine specificities of rheumatoid arthritis-associated autoantibodies. *EBioMedicine*, 71, 103506. https://doi.org/10.1016/j.ebiom.2021.103506
```

### BibTeX

```
@article{romanmelendez2021citrullination,
 author = {Rom{\'a}n-Mel{\'e}ndez, Gabriel D. and Monaco, Daniel R. and Montagne, Janelle M. and Quizon, Rachel S. and Konig, Maximilian F. and Astatke, Mekbib and Darrah, Erika and Larman, H. Benjamin},
 title = {Citrullination of a phage-displayed human peptidome library reveals the fine specificities of rheumatoid arthritis-associated autoantibodies},
 journal = {EBioMedicine},
 volume = {71},
 pages = {103506},
 year = {2021},
 doi = {10.1016/j.ebiom.2021.103506}
}
```

 Rom&aacute;n-Mel&eacute;ndez and colleagues adapted Phage ImmunoPrecipitation Sequencing (PhIP-Seq) to the quantitative analysis of antibody reactivity against an enzymatically citrullinated human peptidome library, enabling proteome-scale, epitope-resolved characterization of anti-citrullinated protein antibody (ACPA) responses in rheumatoid arthritis. Comparing PAD2- and PAD4-modified versions of a ~250,000-peptide 90-mer library against unmodified counterparts, the assay distinguished citrulline-dependent autoreactivities and resolved PAD-isoform-specific ACPA fingerprints in individual patients — moving the RA serology biomarker from pan-CCP positivity to per-epitope, per-PAD-isoform resolution.

 [
 Read publication at EBioMedicine
 
 ](https://doi.org/10.1016/j.ebiom.2021.103506)

In this publication:

 - **~250,000-peptide 90-mer library** spanning the human proteome was enzymatically modified in vitro with recombinant human PAD2 and PAD4, then run alongside unmodified counterparts in a head-to-head PhIP-Seq workflow.

 - **90–95% sensitivity and 100% specificity** against the standard-of-care clinical anti-CCP assay in a cohort of 31 rheumatoid arthritis patients and 10 demographically matched healthy controls.

 - **20 of 21 anti-CCP+ RA patients reacted** to PAD2- and/or PAD4-dependent peptide epitopes, with PAD-isoform-specific ACPA fingerprints distinguished per patient.

 - **Generalizable framework for post-translational autoantigen profiling:** the enzymatic-modification + library-quality-control pipeline is portable to other PTMs (carbamylation, acetylation, phosphorylation), opening proteome-wide autoantibody profiling against modified self.

Rheumatoid arthritis (RA) is associated with autoantibodies that recognize citrullinated proteins — proteins in which the amino acid arginine has been enzymatically converted to citrulline by peptidylarginine deiminase (PAD) enzymes. The clinical anti-cyclic citrullinated peptide (CCP) test is highly informative for RA diagnosis but reports a single global readout: it doesn't tell clinicians which citrullinated targets a given patient's antibodies actually recognize, nor whether those antibodies prefer PAD2- or PAD4-citrullinated substrates.

The authors adapted Phage ImmunoPrecipitation Sequencing (PhIP-Seq) — a programmable phage-display platform that displays ~250,000 overlapping 90-amino-acid peptide tiles spanning the human proteome — to this problem. They enzymatically citrullinated the library in vitro using recombinant human PAD2 and PAD4 enzymes, established quality-control criteria for the modification, and then mixed each modified library, alongside its unmodified counterpart, with patient serum. Antibody-bound phage clones are immunoprecipitated, PCR-amplified, and quantified by deep DNA sequencing. By comparing read counts between modified and unmodified libraries, peptides whose binding depended on citrullination — the citrulline-specific ACPA targets — could be identified epitope-by-epitope, across the proteome, in an unbiased way.

Applied to a cohort of 31 RA patients and 10 demographically matched healthy controls, the assay was highly concordant with clinical anti-CCP serostatus and resolved PAD-isoform-specific ACPA reactivity profiles among individual patients. The authors propose PAD PhIP-Seq as a powerful, quantitative tool for proteome-scale antibody-binding analyses in RA and, by extension, as a generalizable framework for studying autoantibodies against any post-translationally modified epitope — carbamylation, acetylation, phosphorylation, and others — opening a path to longitudinal monitoring of pre-clinical RA, response to PAD-targeted therapeutics, and novel PTM-associated autoantigen discovery.

 [← Back to all resources](/)

## Related resources

[![](https://cdn.sanity.io/images/vbcbvda6/production/aa97363ccf2216d6365cdd27c5aaefcc489db819-1200x750.webp)Brochure

### HuSIGHT and EnviroSIGHT — InSIGHTs for Parkinson's Disease

HuSIGHT + EnviroSIGHT for Parkinson's research: environmental triggers and autoimmune contributions in one assay.

Read more
](/resources/husight-and-envirosight-insights-for-parkinsons-disease)[![](https://cdn.sanity.io/images/vbcbvda6/production/df6062d9a45026fd7525f846ef6c3f9c3f11fafb-1376x768.webp)Brochure

### Antibody Reactomics: The Responsive Layer of Immune Memory

Where the antibody reactome fits in the multi-omic stack, how MIPSA deciphers it, and what the HuSIGHT, VirSIGHT, and En…

Read more
](/resources/antibody-reactomics-overview)[![](https://cdn.sanity.io/images/vbcbvda6/production/bd98a023e7b99b56fcec6d9b14b0ba00a1435f06-1200x750.webp)Publication

### Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodies

Anti-Sp4 autoantibodies modify cancer risk in TIF1γ-positive dermatomyositis patients.

Read more
](/resources/coexisting-autoantibodies-against-transcription-factor-sp4-are-associated-with-d)[![](https://cdn.sanity.io/images/vbcbvda6/production/bd98a023e7b99b56fcec6d9b14b0ba00a1435f06-1200x750.webp)Publication

### Identification of Caveolae-Associated Protein 4 Autoantibodies as a Biomarker of Immune-Mediated Rippling Muscle Disease in Adults

Anti-cavin-4 autoantibodies as a biomarker for immune-mediated rippling muscle disease.

Read more
](/resources/identification-of-caveolae-associated-protein-4-autoantibodies-as-a-biomarker-of)[![](https://cdn.sanity.io/images/vbcbvda6/production/bd98a023e7b99b56fcec6d9b14b0ba00a1435f06-1200x750.webp)Publication

### Unbiased discovery of autoantibodies associated with severe COVID-19 via genome-scale self-assembled DNA-barcoded protein libraries

Credle et al., Nature Comm 2022: the foundational MIPSA paper introducing antibody reactome profiling.

Read more
](/resources/unbiased-discovery-of-autoantibodies-associated-with-severe-covid-19-via-genome)[![](https://cdn.sanity.io/images/vbcbvda6/production/bd98a023e7b99b56fcec6d9b14b0ba00a1435f06-1200x750.webp)Publication

### PhIP-Seq Reveals Autoantibodies for Ubiquitously Expressed Antigens in Viral Myocarditis

Auto-antibody reactivities against ubiquitously expressed antigens identified in viral myocarditis cohort.

Read more
](/resources/phip-seq-reveals-autoantibodies-for-ubiquitously-expressed-antigens-in-viral-myo)[![](https://cdn.sanity.io/images/vbcbvda6/production/bd98a023e7b99b56fcec6d9b14b0ba00a1435f06-1200x750.webp)Publication

### Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis

Bjornevik et al., Science 2022: 10M serial serum samples link EBV to multiple sclerosis.

Read more
](/resources/longitudinal-analysis-reveals-high-prevalence-of-epstein-barr-virus-associated-w)[![](https://cdn.sanity.io/images/vbcbvda6/production/bd98a023e7b99b56fcec6d9b14b0ba00a1435f06-1200x750.webp)Publication

### TGM4: an immunogenic prostate-restricted antigen

TGM4: an immunogenic, prostate-restricted antigen and research target for prostate cancer.

Read more
](/resources/tgm4-an-immunogenic-prostate-restricted-antigen)[![](https://cdn.sanity.io/images/vbcbvda6/production/bd98a023e7b99b56fcec6d9b14b0ba00a1435f06-1200x750.webp)Publication

### LINE-1 ORF2p expression is nearly imperceptible in human cancers

LINE-1 ORF2p protein expression is rare in human cancers, refining a long-held assumption.

Read more
](/resources/line-1-orf2p-expression-is-nearly-imperceptible-in-human-cancers)[![](https://cdn.sanity.io/images/vbcbvda6/production/bd98a023e7b99b56fcec6d9b14b0ba00a1435f06-1200x750.webp)Publication

### PhIP-Seq characterization of autoantibodies from patients with multiple sclerosis, type 1 diabetes and rheumatoid arthritis

Larman et al., 2013: foundational unbiased autoantibody discovery across MS, T1D, and RA.

Read more
](/resources/phip-seq-characterization-of-autoantibodies-from-patients-with-multiple-sclerosi)[![](https://cdn.sanity.io/images/vbcbvda6/production/bd98a023e7b99b56fcec6d9b14b0ba00a1435f06-1200x750.webp)Publication

### Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis

Anti-cN1A autoantibodies as a research-grade biomarker for sporadic inclusion body myositis.

Read more
](/resources/cytosolic-5-nucleotidase-1a-autoimmunity-in-sporadic-inclusion-body-myositis)[![](https://cdn.sanity.io/images/vbcbvda6/production/bd98a023e7b99b56fcec6d9b14b0ba00a1435f06-1200x750.webp)Publication

### Autoantigen discovery with a synthetic human peptidome

Larman et al., Nat Biotech 2011: foundational synthetic human peptidome paper for autoantigen discovery.

Read more
](/resources/autoantigen-discovery-with-a-synthetic-human-peptidome) Get in Touch [Contact Us](https://www.infinitybio.com/contact/)